Versameb AG’s CHF6 Million Financing Round

VISCHER AG advises Versameb AG in its CHF 6 million seed financing round. Versameb is engaged in the discovery and development of next-generation RNA-based drugs using…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now